Extended Data Fig 7: Best mobility levels passed at baseline and months 1 through 6 following injection(s). | Nature Medicine

Extended Data Fig 7: Best mobility levels passed at baseline and months 1 through 6 following injection(s).

From: Effect of an intravitreal antisense oligonucleotide on vision in Leber congenital amaurosis due to a photoreceptor cilium defect

Extended Data Fig 7

a, Mobility results recorded in both eyes of all subjects. b, Change in mobility from baseline. c, Interocular difference (treated eye minus untreated eye) between mobility levels. Larger symbols in panels b–c are averages from 9 patients at baseline, 8 patients at month 1, 7 patients at months 2 and 3, and 4 patients at month 6. Error bars, ±1 s.d.

Back to article page